Envista Holdings Corporation

dental business

NVST NYSE ISIN US29415F1049 SEC CIK 1757073 LEI 549300BX623VURJZ5269
Follow Envista Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $691.5M +3.2% vs same quarter last year
Net income $508.3M +1777.6% vs same quarter last year
EPS, diluted $3.11 +1827.8% vs same quarter last year
Operating cash flow $77.9M −1% vs same quarter last year
Revenue by quarter
$652.9M
$616.9M
$682.1M
$669.9M
$750.6M
$705.5M
$730.5M
$691.5M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$2B−$1B$0$1B$2B$3BFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$2.7B$47M
FY24$2.5B−$1.1B
FY23$2.6B−$100.2M
FY22$2.6B$243.1M
FY21$2.5B$340.5M
FY20$1.9B$33.3M
FY19$2.3B$217.6M
FY18$2.8B$230.7M
FY17$2.8B$301.1M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2554.7%7.9%1.7%
FY2454.7%−41.4%−44.6%
FY2356.1%1.2%−3.9%
FY2257.4%12.4%9.5%
FY2156.9%12.2%13.6%
FY2054.7%2.3%1.7%
FY1959.1%10.3%9.5%
FY1856.3%10.5%8.1%
FY1757.7%13.8%10.7%
Free cash flowOperating cash flow minus capital expenditure
$0$100M$200M$300M$400MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$230.4M
FY24$302.7M
FY23$217.5M
FY22$107M
FY21$306.9M
FY20$236.2M
FY19$319.7M
FY18$327.9M
FY17$310.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Envista
  • Healthcare median
−100%−75%−50%−25%0%25%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearEnvistaHealthcare median
FY251.7%−30.6%
FY24−44.6%−47%
FY23−3.9%−58%
FY229.5%−80.4%
FY2113.6%−71.9%
FY201.7%−62.2%
FY199.5%−46.3%
FY188.1%−49.6%
FY1710.7%−45.9%